A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
CONFIDENCE
CONFIDENCE: A Pilot Randomized Control Trial With Waitlist Condition to Test a Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
1 other identifier
interventional
667
1 country
1
Brief Summary
The goal of this study is to refine and test CONFIDENCE, a multi-component clinic-based intervention in pediatric or family practice clinical settings. Using a randomized control trial design, the investigators will assess preliminary effectiveness of the intervention to increase COVID-19 vaccine intention among parents of under-vaccinated children ages 5 to 17. Participating clinics will receive a brief intervention consisting of: (1) webinar training focused on communication with vaccine-hesitant parents, (2) parent-facing educational materials about COVID-19 vaccination, (3) support to create a personalized, poster campaign featuring providers. Clinics in the control condition will receive the intervention approximately 12 months after the clinics in the intervention condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Start
First participant enrolled
March 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedJanuary 14, 2025
January 1, 2025
1.6 years
February 8, 2023
January 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
COVID-19 vaccine intention
Parent exit survey in clinics: Parents will report their intention to vaccinate their children for COVID-19. See survey question below: "Did you decide to vaccinate your child against COVID-19 today? Yes/No"
Data collection will occur in the four weeks following implementation
Secondary Outcomes (9)
Feasibility: Recruitment
End of study; approximately 15 months
Feasibility: Data Completeness
End of study; approximately 15 months
Feasibility: Randomization
End of study; approximately 15 months
Acceptability: Parents
Four to eight weeks post implementation
Perceived appropriateness: Parents
Four to eight weeks post implementation
- +4 more secondary outcomes
Study Arms (2)
Intervention Condition
EXPERIMENTALWaitlist Condition
ACTIVE COMPARATORClinics in this condition will receive the intervention approximately 12 months after the intervention condition.
Interventions
This clinic-based, multicomponent intervention consists of 3 parts: 1. Webinar training for clinicians and clinic staff about how to communicate with vaccine-hesitant parents 2. Parent-facing educational materials about COVID-19 vaccination 3. Support in creating a personalized poster campaign featuring providers and clinic staff sharing personal stories about COVID-19 vaccination
Eligibility Criteria
You may qualify if:
- Pediatric or family practice clinic that serves pediatric population (ages 5 to 17)
- Affiliated with UMass Memorial Health Care and/or Baystate Health
- Serve a patient population that is at least 30% racial/ethnic minority group members.
- Parent/guardian (referred to as parents in this proposal) of child between ages 5 and 17
- Able to read and write in English, Spanish, Portuguese or Vietnamese, which are the predominant languages in the target communities
- Parent of patient at participating clinical site/child received non-urgent care visit during study period
- Child not up-to-date for COVID-19 per current CDC guidelines at the time of enrollment.
You may not qualify if:
- °Parent under age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Massachusetts, Worcesterlead
- Merck Sharp & Dohme LLCcollaborator
- Baystate Healthcollaborator
Study Sites (1)
UMass Chan Medical School
Worcester, Massachusetts, 01605, United States
Related Publications (1)
Ryan GW, Goulding M, Borg A, Minkah P, Beeler A, Rosal MC, Lemon SC. Development and Beta-Testing of the CONFIDENCE Intervention to Increase Pediatric COVID-19 Vaccination. J Pediatr Health Care. 2023 May-Jun;37(3):244-252. doi: 10.1016/j.pedhc.2022.11.002. Epub 2022 Nov 17.
PMID: 36470798BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephenie C Lemon, PhD
University of Massachusetts Chan Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Clinics will know if they are assigned to the intervention or control condition. However, individual participants (parents of children ages 5 to 17) will not know if their clinic is in the intervention or control condition.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chief of the Division of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences
Study Record Dates
First Submitted
February 8, 2023
First Posted
February 10, 2023
Study Start
March 27, 2023
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
January 14, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available will be available upon publication of the primary outcomes manuscript from this project.
- Access Criteria
- Data will be made available upon reasonable request from researchers.
A de-identified individual-level dataset will be made available to researchers who make a reasonable request to the principal investigator. Data will be made available upon publication of the primary outcomes manuscript.